COSCIENS Biopharma Inc. (CSCIF) stock
CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
$6.49+0.00 (0.00%)
Close on Oct 19, 2026Market cap $24.10MP/E –Yield –
COSCIENS Biopharma cash
Cash and short-term investments held at the end of each period.
COSCIENS Biopharma's cash was $5.01M at Mar 31, 2026. For fiscal 2025 it was $7.31M, down 55.4% from the year before. Over ten years it grew -15.9% a year on average. The highest annual figure on record is $41.45M in fiscal 2015.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.31M | -55.4% |
| FY2024 | Dec 31, 2024 | $16.39M | +145.5% |
| FY2023 | Dec 31, 2023 | $6.68M | -34.5% |
| FY2022 | Dec 31, 2022 | $10.19M | +65.5% |
| FY2021 | Dec 31, 2021 | $6.16M | -74.6% |
| FY2020 | Dec 31, 2020 | $24.27M | +209.7% |
| FY2019 | Dec 31, 2019 | $7.84M | -46.0% |
| FY2018 | Dec 31, 2018 | $14.51M | +86.5% |
| FY2017 | Dec 31, 2017 | $7.78M | -64.6% |
| FY2016 | Dec 31, 2016 | $22.00M | -46.9% |
| FY2015 | Dec 31, 2015 | $41.45M | +18.7% |
| FY2014 | Dec 31, 2014 | $34.93M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | $5.01M | -63.6% |
| Q4 FY2025 | Dec 31, 2025 | $7.31M | -55.4% |
| Q3 FY2025 | Sep 30, 2025 | $8.52M | -57.4% |
| Q2 FY2025 | Jun 30, 2025 | $9.33M | -66.4% |
| Q1 FY2025 | Mar 31, 2025 | $13.76M | +292.4% |
| Q4 FY2024 | Dec 31, 2024 | $16.39M | +145.5% |
| Q3 FY2024 | Sep 30, 2024 | $20.00M | +139.1% |
| Q2 FY2024 | Jun 30, 2024 | $27.80M | +225.7% |
| Q1 FY2024 | Mar 31, 2024 | $3.51M | -62.3% |
| Q4 FY2023 | Dec 31, 2023 | $6.68M | -34.5% |
| Q3 FY2023 | Sep 30, 2023 | $8.36M | -84.5% |
| Q2 FY2023 | Jun 30, 2023 | $8.54M | -85.3% |
| Q1 FY2023 | Mar 31, 2023 | $9.30M | -85.4% |
| Q4 FY2022 | Dec 31, 2022 | $10.19M | +65.5% |
| Q3 FY2022 | Sep 30, 2022 | $53.82M | -20.9% |
| Q2 FY2022 | Jun 30, 2022 | $58.16M | -16.8% |
| Q1 FY2022 | Mar 31, 2022 | $63.60M | -13.3% |
| Q4 FY2021 | Dec 31, 2021 | $6.16M | -74.6% |
| Q3 FY2021 | Sep 30, 2021 | $68.00M | +212.7% |
| Q2 FY2021 | Jun 30, 2021 | $69.87M | +936.2% |
| Q1 FY2021 | Mar 31, 2021 | $73.37M | +699.1% |
| Q4 FY2020 | Dec 31, 2020 | $24.27M | +209.7% |
| Q3 FY2020 | Sep 30, 2020 | $21.75M | +100.2% |
| Q2 FY2020 | Jun 30, 2020 | $6.74M | -30.4% |
| Q1 FY2020 | Mar 31, 2020 | $9.18M | -19.2% |
| Q4 FY2019 | Dec 31, 2019 | $7.84M | -46.0% |
| Q3 FY2019 | Sep 30, 2019 | $10.86M | -35.3% |
| Q2 FY2019 | Jun 30, 2019 | $9.68M | -51.5% |
| Q1 FY2019 | Mar 31, 2019 | $11.36M | -53.7% |
| Q4 FY2018 | Dec 31, 2018 | $14.51M | +86.5% |
| Q3 FY2018 | Sep 30, 2018 | $16.80M | -23.6% |
| Q2 FY2018 | Jun 30, 2018 | $19.95M | -51.9% |
| Q1 FY2018 | Mar 31, 2018 | $24.55M | -29.7% |
| Q4 FY2017 | Dec 31, 2017 | $7.78M | – |
| Q4 FY2016 | Dec 31, 2016 | $22.00M | – |
| Q4 FY2015 | Dec 31, 2015 | $41.45M | – |
| Q4 FY2014 | Dec 31, 2014 | $34.93M | – |
See a number that looks wrong?